India's IT firms, including TCS, Infosys, HCL Tech, and Wipro, report growth in deal wins despite global challenges.

HCL Tech Q3's consolidated net profit stood at Rs 4,590 crore, compared to Rs 4,235 crore QoQ. Revenue increased to Rs 29,890 ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of ...

Jones-Hamilton Co. (JH), a leading producer and marketer of hydrochloric acid (HCl) and sodium bisulfate, has announced its ...

The Internet of Things (IoT) is a rapidly evolving field with the potential to reshape how we live, work, and interact with ...

Infosys not only beat analysts’ revenue and profit expectations for the seasonally weak December quarter but also raised its ...

Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent ...

HCLTech's stock decline weighed on the broader market, with the Nifty IT index falling by 0.7%. Despite this, Indian shares ...

As Infosys prepares to release its third-quarter earnings on Thursday, all eyes are on how the company handles challenges ...

HCL Technologies Ltd (NS:HCLT), India’s third-largest IT services ... The Indian IT sector has faced slower growth amid ...

It is estimated that by the end of 2030, some 1.4 million jobs requiring technical proficiency risk going unfilled in the US.

This important study reveals a role for IκBα in the regulation of embryonic stem cell pluripotency. The solid data in mouse embryonic stem cells include separation of function mutations in IκBα to ...